Characterization of a Novel Capsid Assembly Modulator for the Treatment of Chronic Hepatitis B Virus Infection

The standard of care for the treatment of chronic hepatitis B (CHB) is typically lifelong treatment with nucleos(t)ide analogs (NAs), which suppress viral replication and provide long-term clinical benefits. However, infectious virus can still be detected in patients who are virally suppressed on NA...

Descripción completa

Detalles Bibliográficos
Autores principales: Burdette, Dara, Hyrina, Anastasia, Song, Zhijuan, Beran, Rudolf K., Cheung, Tara, Gilmore, Sarah, Kobayashi, Tetsuya, Li, Li, Liu, Yang, Niedziela-Majka, Anita, Medley, Jonathan, Mehra, Upasana, Morganelli, Philip, Novikov, Nikolai, Niu, Congrong, Tam, Danny, Tang, Jennifer, Wang, Jianhong, Yue, Qin, Fletcher, Simon P., Holdorf, Meghan M., Delaney, William E., Feierbach, Becket, Lazerwith, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872672/
https://www.ncbi.nlm.nih.gov/pubmed/36519892
http://dx.doi.org/10.1128/aac.01348-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872672/
https://www.ncbi.nlm.nih.gov/pubmed/36519892
http://dx.doi.org/10.1128/aac.01348-22

Ejemplares similares